Search Results - Ibrahim, Y.
- Showing 1 - 6 results of 6
-
1
-
2
-
3
-
4
-
5
PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer by Serra, V., Scaltriti, M., Prudkin, L., Eichhorn, Pieter, Ibrahim, Y.H., Chandarlapaty, S., Markman, B., Rodriguez, O., Guzman, M., Rodriguez, S., Gili, M., Russillo, M., Parra, J.L., Singh, S., Arribas, J., Rosen, N., Baselga, J.
Published 2011Get full text
-
6
Erratum: RSK3/4 mediate resistance to PI3K pathway inhibitors in breast cancer (Journal of Clinical Investigation (2013) 123:6 (2551-2563) DOI:10.1172/JCI66343) by Serra, V., Eichhorn, Pieter, García-García, C., Ibrahim, Y., Prudkin, L., Sánchez, G., Rodríguez, O., Antón, P., Parra, J., Marlow, S., Scaltriti, M., Pérez-Garcia, J., Prat, A., Arribas, J., Hahn, W., Kim, S., Baselga, J.
Published 2014Get full text